How aminoglycosides are tested on Step 1
Questions ask why an aminoglycoside fails against an abscess or anaerobe, which drug pair is synergistic, or which toxicity explains rising creatinine or hearing loss.
Aminoglycosides need oxygen to get into bacteria, so they never kill anaerobes. And their toxicity lands on the kidney and the inner ear, with neuromuscular blockade as a third, less common risk.
Mechanism
Aminoglycosides are positively charged and enter gram-negative cells through porins, then cross the cytoplasmic membrane by an oxygen-dependent process.
Dosing: concentration-dependent killing
Aminoglycosides kill faster at higher peak concentrations and keep suppressing growth after levels fall (the post-antibiotic effect). Toxicity relates to sustained trough levels.
Uses
Aminoglycosides are mainly reserved for serious gram-negative infections and synergy.
| Agent | Main use |
|---|---|
| Gentamicin | Gram-negative sepsis; synergy for enterococcal and streptococcal endocarditis |
| Tobramycin | Pseudomonas, including inhaled in cystic fibrosis |
| Amikacin | Resistant gram-negatives; nontuberculous mycobacteria |
| Streptomycin | Tuberculosis (second-line), plague, tularemia |
| Neomycin | Oral bowel preparation; hepatic encephalopathy (topical use common) |
Aminoglycosides penetrate poorly into the CNS and lungs and are inactive in abscesses.
Toxicity
Toxicity depends on cumulative exposure and troughs, and adds up with other nephrotoxic and ototoxic drugs.
A patient with Enterococcus faecalis endocarditis is treated with ampicillin plus gentamicin. Why is gentamicin added when it does not work on enterococci alone?
- Enterococci are relatively impermeable to aminoglycosides.
- Ampicillin damages the cell wall, letting gentamicin enter and reach the 30S ribosome.
- The combination becomes bactericidal, which is needed in endocarditis.
Answer. Synergy: the cell-wall agent allows aminoglycoside entry. Ceftriaxone plus ampicillin is an alternative that avoids aminoglycoside nephrotoxicity.
